ZyVersa Therapeutics, Inc. Analysis
| Analyst Ratings |
|
Average Target Price
|
2.50
|
|
Average Rating
|
5.00
|
|
# Strong Buys
|
1
|
|
# Buys
|
0
|
|
# Holds
|
0
|
|
# Sells
|
0
|
|
# Strong Sells
|
0
|
| Quarterly Earnings History |
| Quarter |
EPS Estimate |
EPS Actual |
EPS Difference |
Surprise Percent |
|
2024-09-30
|
-1.60
|
-2.43
|
-0.83
|
-51.88%
|
|
2024-06-30
|
-3.75
|
-3.31
|
0.44
|
11.73%
|
|
2024-03-31
|
-3.70
|
-4.53
|
-0.83
|
-22.43%
|
|
2023-12-31
|
-2.14
|
-13.68
|
-11.54
|
-539.25%
|
|
2023-09-30
|
-0.16
|
-0.09
|
0.07
|
43.75%
|
|
2023-06-30
|
0.00
|
-4.84
|
0.00
|
0.00%
|
|
2023-03-31
|
0.00
|
-0.51
|
-0.51
|
0.00%
|
|
2022-12-31
|
0.00
|
-180.25
|
0.00
|
0.00%
|
| Annual Earnings History |
| Fiscal Year End |
EPS |
|
2024-09-30
|
-10.27
|
|
2023-12-31
|
-19.12
|
|
2022-12-31
|
-180.38
|